The Impact of Brief Corticosteroids on the Clinical Course of Primary Pulmonary Coccidioidomycosis.

Link to article at PubMed

Related Articles

The Impact of Brief Corticosteroids on the Clinical Course of Primary Pulmonary Coccidioidomycosis.

J Infect. 2013 Apr 6;

Authors: Azadeh N, Chang YH, Kusne S, Vikram HR, Seville MT, Orenstein R, Blair JE

Abstract
OBJECTIVE: Primary pulmonary coccidioidomycosis can often be associated with hypersensitivity symptoms treatable with a short course of palliative corticosteroids. Long-term use of corticosteroids is a known risk factor for severe or disseminated infection but the effects of short-term use are not known. METHODS: A retrospective review was conducted of immunocompetent patients with acute pulmonary coccidioidomycosis who received systemic corticosteroids for relief of coccidioidal-related symptoms. Age- and sex-matched controls were also reviewed. Predetermined end-points were assessed. RESULTS: Seventy-four patients met inclusion criteria for the corticosteroid-treated group, and 74 controls were identified. Cumulative corticosteroid (prednisone-equivalent) doses were 10mg 3,600mg (mean=206 mg; median=120mg). Corticosteroids were prescribed most commonly for rash (43/74 [58%] or asthma/wheezing/cough (30/74 [41%]. Coccidioidal-related hospitalization occurred in 19 patients in the corticosteroid group vs. 22 in the control group (P=.58). Coccidioidal-related symptoms resolved within a mean of 19 weeks (median=8 weeks [range=2-208 weeks]) vs. 32.3 weeks (median=8 weeks [range=1-1,040 weeks]) in the corticosteroid and control groups (P=.38). Relapse of symptoms occurred in 12% of both groups (P>.99). Extrapulmonary dissemination occurred in 2.7% vs. 4.0% (P>.99) in the corticosteroid and control groups, respectively. CONCLUSION: This study found no adverse effects of short-term corticosteroid therapy for early symptomatic treatment in acute pulmonary coccidioidomycosis.

PMID: 23570823 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.